Hydrate IV Bar is an IV therapy franchise offering IV drips, vitamin injections and NAD+ treatments, in a full-size IV bar or a smaller "Minibar" format. It is a small system, and its Item 19 is more revealing than most: alongside revenue, it discloses gross profit and operating EBITDA, and the median result is the one to read.
What it costs
| Item | Figure (2026 FDD) |
|---|---|
| Total initial investment, traditional | $347,050–$577,600 |
| Total initial investment, Minibar | $97,300–$162,550 |
| Initial franchise fee | $50,000 ($95,000 for two units, $140,000 for three) |
| Leasehold improvements | $100,000–$200,000 |
| Additional funds (3–6 months) | $90,000–$150,000 |
| Royalty | 8% of gross revenue |
| Brand contribution | 2% of gross revenue |
| Local marketing | $1,500 per month for digital, plus at least 1% of revenue |
| Technology fee | $850 per month |
Total initial investment, traditional
$347,050–$577,600
Total initial investment, Minibar
$97,300–$162,550
Initial franchise fee
$50,000 ($95,000 for two units, $140,000 for three)
Leasehold improvements
$100,000–$200,000
Additional funds (3–6 months)
$90,000–$150,000
Royalty
8% of gross revenue
Brand contribution
2% of gross revenue
Local marketing
$1,500 per month for digital, plus at least 1% of revenue
Technology fee
$850 per month
A $5,000 discount on the first location is available to qualified veterans, first responders and eligible employees. Medical experience is not required for the traditional model, but every outlet needs licensed clinical staff under medical oversight.
What outlets actually earn
The Item 19 covers franchised outlets open for at least a full year at the end of 2025, 12 of them per one summary of the FDD:
| Measure (2025) | Average | Median | Highest | Lowest |
|---|---|---|---|---|
| Total revenue | $655,781 | $508,908 | $1,669,393 | $245,867 |
| Gross profit | $438,075 | $319,747 | $1,220,488 | $68,027 |
| Operating EBITDA | $114,870 | −$688 | $596,113 | −$108,324 |
Total revenue
- Average
- $655,781
- Median
- $508,908
- Highest
- $1,669,393
- Lowest
- $245,867
Gross profit
- Average
- $438,075
- Median
- $319,747
- Highest
- $1,220,488
- Lowest
- $68,027
Operating EBITDA
- Average
- $114,870
- Median
- −$688
- Highest
- $596,113
- Lowest
- −$108,324
The median is the story. Average revenue is pulled up by one or two strong outlets, the best at $1.67 million, and the median sits about 22% lower. The gap widens further down the P&L: average operating EBITDA is $114,870, but the median outlet was at break-even, and the weakest lost $108,324. With a sample of 12, a couple of outlets decide the average.
Gross profit averages about 67% of revenue, so cost of goods, IV fluids, vitamins, NAD+ and supplies, takes about a third, more than at the IV Nutrition affiliate locations, which spent about 16%. Ask what is included in Hydrate's cost of goods, since definitions vary.
Fees against gross profit
At average revenue, the 10% royalty and brand contribution come to $65,578, the local marketing requirement to about $24,600 and the technology fee to $10,200: about $100,300 a year, roughly 15.3% of revenue and 22.9% of gross profit. At the median outlet, the same fees are about $84,200, 16.5% of revenue and 26.3% of its gross profit.
Even counting only the royalty and brand contribution, about 15% of gross profit, this is the heaviest load against gross profit among the medical brands we have measured, and it explains much of the gap between average and median EBITDA. For an outlet at the median, the franchisor's share of gross profit is larger than anything left for the owner.
The ratio that matters
Against the traditional format's midpoint investment of about $462,325, average revenue of $655,781 gives a revenue-to-investment ratio of roughly 1.42x, close to Prime IV at 1.38x and behind IV Nutrition at 2.05x. On the median, it is about 1.10x.
System size
Summaries of the 2026 FDD put the system at 18 locations, though franchisor marketing cites 30. In the most recent year, the FDD reported no terminations, closures or transfers, and 12 projected openings. Item 3 discloses one dispute with a franchisee over trademark infringement and unfair competition; read it in full.
Who this fits
Hydrate suits an owner who wants a compact IV business with a lower-cost Minibar option, and who values a franchisor that discloses EBITDA rather than revenue alone. It suits operators who can drive volume well above the median, since that is where the model pays.
It fits poorly for a buyer whose realistic outcome is the median, at break-even after a heavy fee stack, and for anyone who cannot recruit nurses at a workable wage.
Before you sign
Ask for outlet-by-outlet revenue and EBITDA, and how EBITDA treats owner and manager pay. Find out how many of the 12 outlets were Minibars, and what the Minibar format earns on its own. Confirm the local marketing and technology fees in Item 6. Then model the outlet at the median in the royalty calculator, and work through Item 19 and the due diligence checklist. Our medical wellness cost comparison covers the category. IV and injection supply distributors, EHRs and lab accounts are compared in our clinical operations directory.
Sources
- 1851 Franchise — Hydrate IV Bar franchise costs and 2026 FDD data
- Frandb — Hydrate IV Bar 2026 FDD summary
Frequently asked questions
- How much does a Hydrate IV Bar franchise cost?
- The 2026 FDD discloses a total initial investment of $347,050 to $577,600 for a traditional IV bar and $97,300 to $162,550 for a Minibar, including a $50,000 initial franchise fee. Multi-unit deals cost $95,000 for two units and $140,000 for three.
- How much does a Hydrate IV Bar make?
- The 2026 FDD reports average 2025 revenue of $655,781 and a median of $508,908 across 12 franchised outlets open a full year, ranging from $245,867 to $1,669,393. Average gross profit was $438,075 and average operating EBITDA $114,870, but the median EBITDA was −$688.
- What are Hydrate IV Bar's ongoing fees?
- An 8% royalty and a 2% brand contribution on gross revenue, $1,500 a month for digital marketing plus at least 1% of revenue for other local marketing, and an $850 monthly technology fee. At average revenue, that is about $100,300 a year.
- Is a Hydrate IV Bar franchise profitable?
- On average, yes: operating EBITDA averaged $114,870 across the 12 outlets. But the median outlet was at break-even, with EBITDA of −$688, so a few strong outlets carry the average. Ask how EBITDA is defined and whether it includes owner or manager pay.
Related guides
Medical Wellness Franchise Costs Compared: TRT, Weight Loss, Med Spa and IV
TRT, hormone, medical weight-loss, medspa and IV franchises compared on FDD figures, and on what their royalties take from gross margin, not just sales.
7 min read
Prime IV Hydration & Wellness Franchise Cost & Review
Prime IV franchise cost: $190,501–$632,193 investment, 7% royalty plus 2% brand fund, and Item 19 averaging $567,075 across 99 spas in 2024 — reviewed.
4 min read
IV Nutrition Franchise Cost & Review
IV Nutrition franchise cost: $198,050–$402,550 investment, 6% royalty on net sales, and Item 19 averaging $616,994 across 19 locations, with affiliate profit data — reviewed.
5 min read
Franchise Royalty Structure: How to Design Fees That Scale
A franchisor guide to royalty models, marketing fund design, and margin-based alternatives for wellness franchise systems.
7 min read
Get an alert when Hydrate IV Bar's numbers change
Franchisors refile their FDD every year, and the figures move. We'll email you when this review is updated with Hydrate IV Bar's new disclosure, plus occasional buyer-side insights. No spam.
Prefer downloads? Browse free resources.